Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

Diagnosis and treatment of arterial hypertension 2021

C Ott, RE Schmieder - Kidney international, 2022 - Elsevier
In the last 4 years, several evidence-based, national, and international guidelines on the
management of arterial hypertension have been published, mostly with concordant …

American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update

L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary

A Al-Makki, D DiPette, PK Whelton, MH Murad… - …, 2022 - Am Heart Assoc
Hypertension is a major cause of cardiovascular disease and deaths worldwide especially
in low-and middle-income countries. Despite the availability of safe, well-tolerated, and cost …

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

JP Law, L Pickup, D Pavlovic, JN Townend… - Journal of Human …, 2023 - nature.com
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

The cardio-kidney patient: epidemiology, clinical characteristics and therapy

K Schuett, N Marx, M Lehrke - Circulation research, 2023 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at high risk to develop cardiovascular
disease with its manifestations coronary artery disease, heart failure, arrhythmias, and …

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists …

D Banerjee, P Winocour, TA Chowdhury, P De… - BMC nephrology, 2022 - Springer
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney
disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor …

Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin

S Campo, A Lacquaniti, D Trombetta… - Journal of Clinical …, 2022 - mdpi.com
Biocompatibility in hemodialysis (HD) has considerably improved in recent decades, but
remains an open issue to be solved, appearing essential to reduce systemic inflammation …

[HTML][HTML] Согласованное мнение российских экспертов по профилактике, диагностике и лечению сердечно-сосудистой токсичности противоопухолевой …

ЮА Васюк, ГЕ Гендлин, ЕИ Емелина… - Российский …, 2021 - cyberleninka.ru
АВ—атриовентрикулярный (ая) АГ—артериальная гипертензия АД—артериальное
давление АТ—артериальный тромбоз АТО—атеротромботические осложнения АТФ …

Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population

EL Fu, J Coresh, ME Grams, CM Clase… - Nephrology Dialysis …, 2023 - academic.oup.com
ABSTRACT Background While American nephrology societies recommend using the 2021
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular …